
Paul Bunn, MD, University of Colorado Cancer Center
Advertisement
Articles by Paul Bunn, MD, University of Colorado Cancer Center
Advertisement
Latest Updated Articles
Analyses of CDK4/6 Inhibitors for MyelopreservationPublished: September 16th 2020 | Updated:
Counseling Patients With NSCLC When KRAS is DetectedPublished: August 3rd 2020 | Updated:
Testing for KRAS Mutations in NSCLCPublished: August 3rd 2020 | Updated:
CDK4/6 Inhibitors & Myelopreservation in Other CancersPublished: September 16th 2020 | Updated:
Reducing the Impact of Chemotherapy-Induced MyelosuppressionPublished: September 16th 2020 | Updated:
Current Management of Oncogene-Driven NSCLCPublished: August 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL
5

















